Oncology Biosimilars Market Opportunities, Business Forecast To 2028

December 12, 2022 ⚊ 1 Min read ⚊ Views 86 ⚊ HEALTH

Oncology Biosimilars Market size is valued at USD 3.5 billion in 2021 and is poised to grow at a significant CAGR of 29.0% over 2022–2028. According to the World Health Organization (WHO), cancer is one of the second most important causes of death worldwide. According to WHO figures, 9.6 million people died from cancer in 2018. These figures emphasize the importance of reducing cancer-related fatalities

Read details: https://precisionbusinessinsights.com/market-reports/oncology-biosimilars-market/

Tags: Oncology Biosimilars Market